§

Furcht et al. V. Furcht et al. V. Furcht et al. V. Ho et al. V. Ho et al.

10251685 (P.T.A.B. Sep. 26, 2014)
Furcht et al. V. Furcht et al. V. Furcht et al. V. Ho et al. V. Ho et al.

3 Cited authorities

  1. Biogen Idec MA, Inc. v. Japanese Foundation for Cancer Research

    38 F. Supp. 3d 162 (D. Mass. 2014)   Cited 5 times

    Civil No. 13–13061–FDS. 05-22-2014 BIOGEN IDEC MA, INC., Plaintiff, v. JAPANESE FOUNDATION FOR CANCER RESEARCH and Bayer Pharma AG, Defendants. E. Anthony Figg, R. Danny Huntington, Seth E. Cockrum, Sharon E. Crane, Rothwell, Figg, Ernst & Manbeck P.C., Washington, DC, Claire Laporte, Donald R. Ware, Foley Hoag LLP, Boston, MA, for Plaintiff. Nels Lippert, Tarter, Krinsky & Drogin LLP, Paula Estrada De Martin, S. Calvin Walden, Wilmer Culter Pickering Hale and Dorr LLP, New York, NY, Elisabeth M

  2. Section 135 - Derivation proceedings

    35 U.S.C. § 135   Cited 287 times   48 Legal Analyses
    Governing interferences

  3. Section 90.1 - Scope

    37 C.F.R. § 90.1   Cited 2 times

    The provisions herein govern judicial review for Patent Trial and Appeal Board decisions under chapter 13 of title 35, United States Code. Judicial review of decisions arising out of inter partes reexamination proceedings that are requested under 35 U.S.C. 311 , and where available, judicial review of decisions arising out of interferences declared pursuant to 35 U.S.C. 135 continue to be governed by the pertinent regulations in effect on July 1, 2012. 37 C.F.R. §90.1